摘要
目的探讨炎琥宁联合α干扰素治疗小儿急性上呼吸道感染的临床效果。方法 122例急性上呼吸道感染患儿分为两组并分别给予炎琥宁治疗及炎琥宁+α干扰素治疗,评估患儿治疗效果。结果观察组患儿治疗有效率(93.4%)与对照组患儿治疗有效率(80.3%)对比,差异有统计学意义(P<0.05)。观察组、对照组患儿血清CRP、IL-6对比,差异有统计学意义(P<0.05)。结论炎琥宁联合α干扰素治疗小儿急性上呼吸道感染效果显著,积极改善患儿炎性指标。
Objective To investigate the clinical effect of Yanhuning combined with interferon alpha in the treatment of acute upper respiratory tract infection. Methods 122 case of acute upper respiratory tract infection were divided into two groups and were given Yanhuning treatment and interferon alpha combined with Yanhuning for treatment,the effects were evaluated. Results The observation group of treatment efficiency was 93.4% and the control group was 80.3%,there was a significant difference between two groups(P〈0.05). The observation group,the control group of serum CRP,IL-6 were compared,there was a significant difference(P〈0.05). Conclusion Yanhuning combined with interferon alpha in treatment of acute upper respiratory tract infection have effect,actively improve the inflammatory index in children.
出处
《中国卫生标准管理》
2016年第22期93-94,共2页
China Health Standard Management
关键词
炎琥宁
Α干扰素
小儿急性上呼吸道感染
Yanhuning
Interferon alpha
Children with acute upper respiratory tract infection